EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Maternal Isoimmunization‐Associated Fetal Anemia After First‐Trimester Abortion: A Case Report and Literature Review

Fatemeh Golshahi iD, Behrokh Sahebdel iD, Fatemeh Rahimi-Sharbaf iD, Mahboobeh Shirazi iD, Nafiseh Saedi iD, Khadijeh Adabi iD, Arash Jafarieh iD, Maedeh Mollaalipour Amiri, Zahra Hamidi Madani iD

Clinical Case Reports · 2026-04 · 14 (4)

DOI: 10.1002/ccr3.72237 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 09.04.2026. Verfasst von Fatemeh Golshahi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Fellowship of Maternal Fetal Medicine Yas Hospital Complex, Tehran University of Medical Sciences Tehran Ira…. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isoimmunization and fetal anemia pose considerable challenges in obstetrics, especially when there is a documented history of RhD incompatibility or other antibodies that may threaten fetal well‐being. These conditions frequently result in serious complications, including hydrops fetalis, fetal anemia, and, in certain situations, fetal loss. Effective management of such pregnancies needs careful monitoring and prompt interventions, such as intrauterine transfusion (IUT), along with thorough post‐delivery follow‐up to safeguard both maternal and neonatal health. Due to ongoing uncertainties concerning the administration of Rh immunoglobulin (RhIg) in RhD‐negative mothers during the first trimester of pregnancy, specifically before 12 weeks of gestation, this rare case series examines two pregnancies complicated by fetal anemia and isoimmunization, emphasizing the clinical trajectory, management approaches, and outcomes for the neonates involved. This presentation discusses two cases of Rh isoimmunized pregnant women with significant histories of early pregnancy loss. The first patient, a 27‐year‐old G3Ab2 woman, had experienced two previous miscarriages—one at 9 weeks induced pharmacologically and another spontaneous abortion at 8 weeks without curettage. She underwent her first intrauterine transfusion (IUT) at 21 weeks and 2 days with an Anti‐D titer of 1:512 and a fetal hemoglobin level of 9.2 mg/dL. A total of two IUTs were performed, and she delivered a healthy neonate at term with normal Apgar and growth. The second patient, a 32‐year‐old G2Ab1 woman, had one prior medically induced abortion at 7 weeks using misoprostol, with no surgical intervention. She received her first IUT at 24 weeks and 5 days, with a lower anti‐D titer of 1:164 and a fetal hemoglobin level of 5.1 mg/dL. Despite requiring four transfusions, she delivered at 37 + 1 weeks a healthy neonate with normal development. In the first case, the newborn presented with a bilirubin concentration 7.2 and exhibited positive results for anti‐D and anti‐C antibodies, both at elevated titers. In the subsequent case, the infant had a birth weight of 3 kg, normal Apgar scores, and a hemoglobin level of 10.1. Upon discharge, the infant was reported to be in stable condition and demonstrated normal growth and development at 37 months of age. The management of abortions occurring before 12 weeks of gestation in women with a negative RhD and fetuses with a positive RhD is crucial for the prevention of isoimmunization. Therefore, it seems reasonable to administer RhIg in abortions under 12 weeks to prevent future consequences.

Schlagwörter

Stichwörter der Autor:innen

anomalyfetal anemiaisoimmunizationpregnancyrh immunoglobulin

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Fellowship of Maternal Fetal Medicine Yas Hospital Complex, Tehran University of Medical Sciences Tehran Iran.
  • Department of Obstetrics and Gynecology, Fellowship of Maternal Fetal Medicine, Maternal Fetal and Neonatal Research Center Yas Hospital Complex, Tehran University of Medical Sciences Tehran Iran.
  • Department of Obstetrics and Gynecology Yas Hospital, Tehran University of Medical Sciences Tehran Iran.
  • Department of Obstetrics and Gynecology, School of Medicine Yas Hospital, Tehran University of Medical Sciences (TUMS) Tehran Iran.
  • Anesthesiology & Critical Care Department Amir A'lam Hospital, Tehran University of Medical Tehran Iran.
  • Tehran University of Medical Sciences, Yas Hospital Complex Tehran Iran.

ORCID-Profile: Fatemeh Golshahi, Behrokh Sahebdel, Fatemeh Rahimi-Sharbaf, Mahboobeh Shirazi, Nafiseh Saedi, Khadijeh Adabi, Arash Jafarieh, Zahra Hamidi Madani

Zitieren

APA

Golshahi, F., Sahebdel, B., Rahimi-Sharbaf, F., Shirazi, M., Saedi, N., Adabi, K., Jafarieh, A., Mollaalipour Amiri, M., & Hamidi Madani, Z. (2026). Maternal Isoimmunization‐Associated Fetal Anemia After First‐Trimester Abortion: A Case Report and Literature Review. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72237

Vancouver

Golshahi F, Sahebdel B, Rahimi-Sharbaf F, Shirazi M, Saedi N, Adabi K, et al. Maternal Isoimmunization‐Associated Fetal Anemia After First‐Trimester Abortion: A Case Report and Literature Review. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72237

BibTeX
@article{Golshahi2026,
  author = {Golshahi, Fatemeh and Sahebdel, Behrokh and Rahimi-Sharbaf, Fatemeh and Shirazi, Mahboobeh and Saedi, Nafiseh and Adabi, Khadijeh and Jafarieh, Arash and Mollaalipour Amiri, Maedeh and Hamidi Madani, Zahra},
  title = {Maternal Isoimmunization‐Associated Fetal Anemia After First‐Trimester Abortion: A Case Report and Literature Review},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/ccr3.72237}
}
Kostenlos starten →